Canabo Medical
Seite 26 von 34 Neuester Beitrag: 25.04.21 00:05 | ||||
| Eröffnet am: | 24.11.16 23:33 | von: Base | Anzahl Beiträge: | 849 |
| Neuester Beitrag: | 25.04.21 00:05 | von: Andreawmtq. | Leser gesamt: | 198.540 |
| Forum: | Hot-Stocks | Leser heute: | 1 | |
| Bewertet mit: |  | |||
| Seite: < 1 | ... | 23 | 24 | 25 | | 27 | 28 | 29 | ... 34 > | ||||
Laut diesem aufschlussreichen Artikel aus dem Alpha Discoverer-Newsletter von Value Digger ist CMM einer der Nischenplayer im Marihuana-Sektor.
Value Digger, der bekannte Finanzautor, ist laut TipRanks in TOP-100 vertreten. Scrollen Sie nach unten, CMM wird im 4. Absatz erwähnt. Loggen Sie sich ein, um mehr Details über Marihuana-Picks zu lesen. Der Link für diesen Artikel ist unten:
https://www.themaven.net/thealphadiscoverer/...UUpY46eiek6MZyAuv0Mmqw
Read more at http://www.stockhouse.com/companies/bullboard/...#3fochuRuFPrEyWeQ.99
Sie haben sogar für 30 Mille (1,25$) die Privatplatzierung machen können, d.h. die Nachfrage war größer als seinerzeit angenommen :-) !
Halifax, Nova Scotia--(Newsfile Corp. - January 30, 2018) - Canabo Medical Inc. (TSXV: CMM) ("Canabo" or the "Company") is pleased to announce that further to its press release dated December 22, 2017 regarding its business combination (the "Proposed Transaction") with Aleafia Inc. ("Aleafia"), Aleafia has increased its brokered private placement of subscription receipts ("Subscription Receipts") on a best efforts basis (the "Aleafia Private Placement") to now raise gross proceeds of approximately $30,000,000 at an offering price of $1.25 per Subscription Receipt. The Proposed Transaction will proceed by way of a three-cornered amalgamation between Aleafia and Canabo's Ontario subsidiary, 2412550 Ontario Inc. The combined listed entity of Aleafia and Canabo is referred to below as the "Resulting Issuer".
Mackie Research Capital Corporation, as the lead agent and sole bookrunner, together with a syndicate of other registered investment dealers including Canacord Genuity Corp. Clarus Securities Inc. and PowerOne Capital Markets Limited (the "Agents") have been appointed as the exclusive agents for the Aleafia Private Placement. The Agents will have the option exercisable any time up to 24 hours prior to the closing of the Aleafia Private Placement to increase the size of the offering by up to 15% (the "Over-Allotment Option"), for a total offering size of $34,500,000. Each Subscription Receipt will, following the completion of the Proposed Transaction, and the satisfaction of certain escrow release conditions, entitle the holders to receive, without payment of additional consideration or taking of further action, one (1) unit consisting of one (1) common share and one half (1/2) of a common share purchase warrant in the capital of the Resulting Issuer, as previously announced. Each whole warrant will be exercisable into one (1) common share in the Resulting Issuer at a price of $1.75 for 18 months following the date of listing of the Resulting Issuer's common shares on the TSX Venture Exchange (the "Listing Date").
The Agents shall receive a cash commission equal to 6.0% and will be issued compensation options (the "Compensation Options") to purchase the number of units of the Resulting Issuer equal to 6.0% of the number of Subscription Receipts sold at a price of $1.25 for a period of 18 months from the Listing Date (excluding the gross proceeds raised from investors on the President's List (as defined below) for which there will be only a 3% cash commission and 3.0% in Compensation Options issued). Aleafia will provide the Agents with a list of eligible purchasers together with an allocation for such purchasers (the "President's List"), which allocation may only be varied upon Aleafia's agreement.
On the Listing Date, the gross proceeds from the Aleafia Private Placement, less the any Agents' expenses incurred up to and including the Listing Date, will be deposited into escrow, pending completion of the proposed Transaction. If for any reason the Proposed Transaction does not close, then the gross proceeds will be refunded to the subscribers without penalty or deduction. Upon completion of the Proposed Transaction, it is expected that the Resulting Issuer will meet the listing requirements of an Exchange Tier 1 life sciences issuer.
Further details with respect to the Proposed Transaction and the Aleafia Private Placement, as well as a description of Aleafia and its business, is contained in Canabo's news release dated December 22, 2017.
The completion of the Proposed Transaction is expected to occur on the day that is the seventh business day following the satisfaction or waiver of the conditions precedent or such other date as mutually agreed to by the Company and Aleafia, but in any event no later than March 30, 2018. Each of the Company and Aleafia will bear its own respective costs and expenses associated with the Proposed Transaction.
Overview of Aleafia
Aleafia operates the Aleafia Total Health Network in Vaughan, Ontario. Aleafia seeks to make a difference in cannabinoid therapy delivery by providing an interconnected medical service model. While most clinical programs are geared primarily towards post injury rehabilitation, Aleafia is focused on the strong link between early intervention and successful treatment. The intent is to manage health through a patient focused, assessment based, and interdisciplinary resourced organization.
Der Kurs wird nicht mehr unter dern 1,25 eröffnen, denke eher zügig auf die 2-3 $ zugehen.
Bei 4$ gehe ich mit meinem Einsatz raus und lasse nur die Gewinne weiterlaufen ;-)
Lassen wir uns überraschen, hoffe auf eine Notierung in den nächsten 14 Tagen ->
The completion of the Proposed Transaction is expected to occur on the day that is the seventh business day following the satisfaction or waiver of the conditions precedent or such other date as mutually agreed to by the Company and Aleafia
DIe Möglichkeiten in der Verwendung alleine im medizinischen MH sind gewaltig und da hat CMM einen großen Vorteil durch Ihre Studien. Ich bin ja schon sehr gespannt was der Zusammenschluss im Endeffekt für positive Überraschungen bringen wird!
Die Vielfältigkeit der Verwendung des Cannabis ist schon sehr gewaltig, "früher" hast du es geraucht, jetzt kannst du es lutschen, trinken, essen, etc...und wo ist der Unterschied zum Alkohol? Ist natürlich nur meine subjektive Meinung zum Thema und auch keine Kauf-Verkaufsentscheidung!
Canabo Medical IncSymbolC: CMMAktien ausgegeben37,962,461Schließen 2017.12.22C $ 0,69Kürzliche Sedar Dokumente
Originalbeleg anzeigen
Canabo gibt definitive Einigung mit Aleafia
2018-02-02 02:05 ET - Pressemitteilung
Herr John Philpott berichtet
CANABO MEDICAL INC. KÜNDIGT ENDGÜLTIGE VEREINBARUNG MIT ALEAFIA INC.
Canabo Medical Inc. hat eine definitive Vereinbarung in Bezug auf den Unternehmenszusammenschluss mit Aleafia Inc. abgeschlossen, einer privaten Gesellschaft, die nach den Gesetzen von Ontario mit Sitz in Concord, Ontario, existiert. Aleafia betreibt das Aleafia-Gesamtgesundheitsnetzwerk in Vaughan, Ontario, und besitzt eine Tochtergesellschaft, die in Kanada lizenziert ist, um medizinisches Marihuana anzubauen.
Die endgültige Vereinbarung sieht vor, dass die geplante Transaktion im Rahmen einer Dreiecksvereinigung zwischen Canabo, Canabos hundertprozentiger Tochtergesellschaft 2412550 Ontario Inc. (TCMC) und Aleafia abgeschlossen wird, wobei TCMC und Aleafia zu einer zusammengeschlossenen Gesellschaft verschmelzen werden. Am Tag des Inkrafttretens der Verschmelzung erhalten alle Aktionäre von Aleafia am Tag des Inkrafttretens Stammaktien der Gesellschaft im Verhältnis 1: 1, und alle ausstehenden Aktienoptionen und Optionsscheine von Aleafia werden wirksam Das Datum wird auf äquivalenter Basis gegen Aktienoptionen und Optionsscheine der Gesellschaft ausgetauscht.
Nach Abschluss des Zusammenschlusses und vorbehaltlich der Annahme der TSX Venture Exchange werden die Stammaktien von Canabo weiterhin an der TSX-V notiert, wobei alle Aktionäre von Aleafia ebenfalls Aktionäre von Canabo werden und rund 71 Prozent an der TSX-V halten werden die insgesamt ausgegebenen Aktien der Gesellschaft vor Abschluss der Privatplatzierung von Aleafia (wie hierin definiert). Canabo wird der sich daraus ergebende börsennotierte Emittent sein und weiterhin alle anderen Geschäfte und Immobilien sowie die von Aleafia halten, und der sich daraus ergebende Emittent wird alle Verbindlichkeiten des Unternehmens zusammen mit allen Verbindlichkeiten von Aleafia auf einem konsolidierten Emittenten haben Basis. Die geplante Transaktion wird gemäß den Richtlinien der TSX-V als fundamentaler Erwerb behandelt.
Da bin ich mal gespannt was mit Canabo passiert wenn sie dann nächste Woche eventuell wieder gehandelt wird.
Kurse von 3-4 Dollar sind meiner Meinung nach nur durch den Hype im gesamten Sektor möglich.
Hätte ja mit der tatsächlichen Bewertung nichts zu tun.
Bei ca. 130 Millionen Aktien wären wir bei 3 $ bei einem Marktwert von 390 mio. $.
Cananbo hat im ersten Jahr ca. 4 mio $ Umsatz gemacht.
Man darf gespannt sein.
Question:
Hello Mr. Stewart: If time permits can you give any info on the current Business Combination with ALeafia ? I have read the lastest news but there is no indication the Combination is a Done Deal... Also can you reassure me and my colleagues that the combination will be forth coming .With such a delay I am sure you can see our concerns.Thank you for your time and effort..Ronald MacDonell( Shareholder)
Response:
Ronald:
I really can’t tell you any more than what is in the press releases. We are on schedule with the process, the definitive agreement is signed and both parties area working to close the $30,000,000 ($34,000,000 with over allotment) private placement ASAP. The schedule has a completion date of not beyond March 31 and there is every expectation it will be done before that.
Big Boost for Medical Cannabis
This week, Sun Life, which offers group health insurance plans to over 22,000 employers with more than three million under coverage in Canada, said that they will begin providing reimbursement for medical cannabis. While the coverage is limited for now to just a few qualifying conditions, this is a monumental milestone. Importantly, the company suggested that as data proves out its efficacy in treating other conditions, it will expand the list of qualifying conditions.
Several of the licensed producers in Canada are currently performing clinical trials, and this work, along with the efforts of many of the cannabis clinics there could give Sun Life and hopefully other insurance providers the data they need to broaden reimbursement. While many are focusing on the pending adult-use market, Canada's medical market could drive significant growth for the industry as well, despite its seemingly smaller size as LPs and their partners develop novel therapies based on different cannabinoid/terpene profiles and delivery systems.
At last report (9/30), Health Canada reported 236K total patients, a number that likely has increased to about 280K today, which represents less than 1% of all Canadians and likely less than half of a mature market. One of the bottlenecks has been the complexity of becoming a patient, which has resulted in the development of medical cannabis clinics, several of which have been acquired by LPs. Some of these chains trade publicly, like National Access Corp, which won one of four retail licenses in Manitoba, and Canabo Medical, which is combining with Aleafia and acquiring a licensed producer (AeroFarms).
Dauert mMn nicht mehr lange, dann geht's wieder los an der Börse :-)